More about

Interferon

Clinical Guidance
Measles
Overview

Immunology

Gary S. Marshall, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance
Multiple Sclerosis
Assessment and Treatment

Treatment Options

Pavan Bhargava, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

News
June 19, 2024
1 min read
Save

‘Major advancement’: Interferon signature may be helpful biomarker in pediatric Sjögren’s

‘Major advancement’: Interferon signature may be helpful biomarker in pediatric Sjögren’s

Most pediatric patients with Sjögren’s disease displayed an interferon signature in their blood and parotid gland tissue, which could help confirm diagnoses and shorten treatment delays, according to data presented at EULAR 2024 Congress.

News
October 19, 2023
1 min read
Save

Diroximel fumarate linked to better outcomes compared with interferon in MS at 96 weeks

Diroximel fumarate linked to better outcomes compared with interferon in MS at 96 weeks

For those with relapsing-remitting MS, treatment with diroximel fumarate was linked to better outcomes at 96 weeks compared with those given interferon beta-1a, according to a presentation at ECTRIMS 2023.

News
June 22, 2023
2 min read
Save

AAAAI-funded research to probe new discoveries in EoE, interferon signaling

AAAAI-funded research to probe new discoveries in EoE, interferon signaling

Researchers will study connections between eosinophilic esophagitis and interferon signaling, possibly paving the way for new treatments, with funding from the AAAAI Foundation’s 2023 Faculty Development awards.

News
February 28, 2023
1 min read
Save

CAR T-cell therapy, new drugs ushering in ‘lupus renaissance’

CAR T-cell therapy, new drugs ushering in ‘lupus renaissance’

SCOTTSDALE, Ariz. — Several new drugs and promising therapies, including chimeric antigen receptor T-cell therapy, have ushered in a “lupus renaissance,” said a speaker at the Basic and Clinical Immunology for the Busy Clinician symposium.

News
February 09, 2023
2 min read
Save

Early pegylated interferon lambda treatment for COVID-19 reduces hospitalization, ED visits

Early pegylated interferon lambda treatment for COVID-19 reduces hospitalization, ED visits

A single dose of pegylated interferon lambda used as early treatment in patients with COVID-19 was effective in lowering the total occurrences of hospitalization and ED visits, a study published in The New England Journal of Medicine found.

News
January 27, 2023
2 min read
Save

Addition of interferon alfa to adjuvant temozolomide extends survival in high-grade glioma

Addition of interferon alfa to adjuvant temozolomide extends survival in high-grade glioma

The addition of interferon alfa to temozolomide significantly extended survival among patients with newly diagnosed high-grade gliomas, according to data published in JAMA Network Open.

News
November 08, 2022
2 min read
Save

Antiviral activity of VIR-2218 boosted by immunomodulators in treatment of chronic HBV

Antiviral activity of VIR-2218 boosted by immunomodulators in treatment of chronic HBV

WASHINGTON — Pegylated interferon alpha potentiated the antiviral activity of VIR-2218 in a small subset of noncirrhotic patients with chronic hepatitis B, according to preliminary data presented at The Liver Meeting.

News
May 24, 2022
3 min read
Save

Inhaled interferon falls short for COVID-19 discharge, recovery but hints of other benefits: SPRINTER

Inhaled interferon falls short for COVID-19 discharge, recovery but hints of other benefits: SPRINTER

SAN FRANCISCO — Treatment with inhaled interferon beta failed to improve discharge and recovery in patients hospitalized with moderate COVID-19, according to results of the phase 3 SPRINTER trial.

View more